Prolongation of cardiac xenograft survival by pre- and posttransplant splenectomy is associated with a decrease in anti-donor antibody titers.
Quarantillo
P
P
Department of Surgery, East Carolina University School of Medicine, Greenville, North Carolina.
Araneda
D
D
Thomas
F
F
Thomas
J
J
D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000032:analysis*; D000920:Antibody-Dependent Cell Cytotoxicity; D006224:Cricetinae; D016572:Cyclosporine / Q000627:therapeutic use; D003602:Cytotoxicity, Immunologic; D006085:Graft Survival / Q000276:immunology*; D016027:Heart Transplantation / Q000276:immunology*; D007165:Immunosuppression Therapy / Q000379:methods; D051381:Rats; D011917:Rats, Inbred Lew; D013156:Splenectomy; D014183:Transplantation, Heterologous / Q000276:immunology*
D000888:Antibodies, Anti-Idiotypic; D016572:Cyclosporine